A detailed history of Trust CO Of Vermont transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Trust CO Of Vermont holds 6,200 shares of OCUL stock, worth $52,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,200
Previous 6,200 -0.0%
Holding current value
$52,700
Previous $42,000 26.19%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$4.2 - $8.69 $840 - $1,738
200 Added 3.33%
6,200 $42,000
Q4 2023

Mar 08, 2024

BUY
$2.08 - $4.52 $2,080 - $4,520
1,000 Added 20.0%
6,000 $26,000
Q3 2023

Nov 27, 2023

BUY
$3.14 - $5.04 $3,140 - $5,040
1,000 Added 25.0%
5,000 $15,000
Q4 2022

Feb 09, 2023

BUY
$2.61 - $4.41 $10,440 - $17,640
4,000 New
4,000 $11,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.